PT  - JOURNAL ARTICLE
AU  - Debebe Shaweno
AU  - Katherine Horton
AU  - Richard Hayes
AU  - Peter J. Dodd
TI  - Assortative social mixing and sex disparities in tuberculosis burden
AID  - 10.1101/2020.11.18.20233809
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.18.20233809
4099  - http://medrxiv.org/content/early/2020/11/20/2020.11.18.20233809.short
4100  - http://medrxiv.org/content/early/2020/11/20/2020.11.18.20233809.full
AB  - Globally, men have higher tuberculosis (TB) burden but the mechanisms underlying this sex disparity are not fully understood. Recent surveys of social mixing patterns have established moderate preferential within-sex mixing in many settings. This assortative mixing could amplify differences from other causes. We explored the impact of assortative mixing and factors differentially affecting disease progression and detection using a sex-stratified deterministic TB transmission model. We explored the influence of assortativity at disease-free and endemic equilibria, finding stronger effects during invasion and on increasing male:female prevalence (M:F) ratios than overall prevalence. Variance-based sensitivity analysis of endemic equilibria identified differential progression as the most important driver of M:F ratio uncertainty. We fitted our model to prevalence and notification data in examplar settings within a fully Bayesian framework. For our high M:F setting, random mixing reduced equilibrium M:F ratios by 12%(95%CrI 0 - 30%). Equalizing male case detection there led to a 20% (95%CrI 11 - 31%) reduction in M:F ratio over 10 years - insufficient to eliminate sex disparities. However, this potentially achievable improvement was associated with a meaningful 8%(95%CrI 4 - 14%) reduction in total TB prevalence over this time frame.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDSA is supported under the EDCTP2 programme supported by the European Union (grant number RIA2016S-1632-TREATS). PJD is supported by a Career Development Award from the UK MRC (MR/P022081/1). This UK funded award is part of the EDCTP2 programme supported by the European Union.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a mathematical modelling of tuberculosis transmission. Therefore, the study did not collect data from human subjects. We used publicly available prevalence and notifications data (from published reports), and thus IRB approval was not soughtAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLink to the model codes is presented in the manuscript